Our study shows that low CCL14 expression is associated with poorer prognosis in HCC, and infiltration of various types of immune cells, including B cells, DCs, macrophages, neutrophils, CD4+, and CD8+ T cells. Here, CCL14 is linked to hepatocellular carcinoma.